Clinical Trial: Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects (INTORACT)
Sponsor and Collaborators
Wyeth
Contact
Contact: Pfizer CT.gov Call Center
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com
Continue Reading
Principal Investigator
Study Director: Pfizer CT.gov Call Center
ClinicalTrials.gov Identifier
NCT00631371